TS-161
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TS-161, covering 2025-06-10 to 2025-06-10. Get the full timeline:
Most recent: Clinical Trial Update: Antidepressant Effects of TS-161 in Treatment-Resistant Depression [Phase 2]